Back to search

National and Kapodistrian University of Athens

Μελέτη κόστους - χρησιμότητας της θεραπευτικής αντιμετώπισης των ασθενών με υπέρταση στην Ελλάδα

Abstract

dc:description

Resource allocation decisions between competing alternatives within an organized health system constitute a constant and necessary process, especially within the context of the current economic status quo. Hypertension, one of the major public health issues and, also, one of the major contributors to health care expenditure, could not be an exception. In light of the above, the aim of the present dissertation was to perform an economic evaluation of one of the principal interventions to reduce the disease burden of hypertension, i.e. the pharmacological treatment. For that purpose, a cost – utility analysis of hypertension treatment versus a hypothetical no-treatment strategy, taking into account a long-term timeframe with the development of a Markov model, was used as the primary approach. Secondarily, a short term cost – effectiveness analysis that focused on clinical endpoints, as well as a cost – of – illness analysis of hypertension, were performed. The data for the analyses were derived from a prospective observational study of the management of hypertension in Greece. The results indicated that hypertension treatment represents an intervention accompanied by highly favorable incremental cost – utility ratios (3,539 – 5,485€ per QALY gained), especially for certain patient subgroups, such as men smokers. The short term cost – effectiveness analysis confirmed the clinico-economic value of treatment, specifically focusing on the impact of disease severity, on outcomes. Finally, the cost-of-illness analysis, apart from calculating the average total annual cost per patient with hypertension according to disease severity, also highlited the total economic burden, attributed to the disease. The latter is estimated at 3.6 billion Euros, annually, or 1.6% of the country’s Gross Domestic Product. The outcomes of the present study highlight the significance of hypertension as a health priority, as well as the value of treatment, as a health policy intervention. The data presented here, accompanied with similar data for the major diseases/public health problems can constitute important inputs in the decision making process for the improvement of the allocative efficiency of the system and, consequently, the improvement of the efficiency of health services in terms of health status of the population and, finally, the societal welfare.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Athanasakis, Konstantinos
  • Αθανασάκης, Κωνσταντίνος

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/31760

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Athanasakis, Konstantinos; Αθανασάκης, Κωνσταντίνος. Μελέτη κόστους - χρησιμότητας της θεραπευτικής αντιμετώπισης των ασθενών με υπέρταση στην Ελλάδα. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/31760